The promise of personalized health is everywhere, from the local medspa to the fitness influencer on your feed. The reality of delivering it, however, is a thicket of clinical oversight, pharmacy logistics, and state-by-state licensing that most wellness entrepreneurs are not equipped to navigate. This gap, between consumer demand for hormone optimization or peptide therapies and the small businesses trying to meet it, is where Altro Health has planted its flag. The New York-based startup is building what its lead investor calls a "clinical Shopify for wellness," a backend platform that handles the regulated parts so coaches and trainers can focus on the client relationship [NFX, June 2026].
Founded in 2025 by Andrea Corleto and Jennifer Arnold, Altro recently closed a $7 million seed round led by NFX, with participation from Founder Collective and Abby Miller Levy [Athletech News, October 2026]. The capital is earmarked for product development and hiring, as the company scales its infrastructure to support what it says are already "thousands" of users on its platform [Altro Health Blog Post, October 2026].
The Infrastructure Wedge
Altro’s product is not a consumer app. It is a white-label clinical operating system sold to businesses like personal training studios, medspas, health coaches, and gyms. The platform bundles the components required to offer services like lab testing, prescriptions for peptides (including GLP-1s), and hormone replacement therapy under the business’s own brand. Altro provides the licensed clinicians, pharmacy network, compliance guardrails, and software to manage it all, with month-to-month pricing and no long-term contracts [Altro Health, retrieved 2026].
The wedge is pragmatic. A solo entrepreneur can now add a high-margin, sticky clinical service to their offering without needing to hire a medical director, establish a lab partnership, or decipher 50 different state telemedicine laws. For the client, the experience is smooth, appearing to come directly from their trusted coach or spa. Altro operates in the background, ensuring prescriptions are issued appropriately and lab results are interpreted by its clinical team. The company reports its services are now available in all 50 states and Washington, D.C., a significant regulatory hurdle cleared [Altro Health Blog Post, October 2026].
A Founder Pair Forged in the Clinic
The company’s origins are in its founders’ previous venture, Lyv Health, a virtual longevity clinic they operated before pivoting to the infrastructure model [PERPLEXITY SONAR PRO BRIEF, Unknown]. That direct experience trying to scale a clinic revealed the immense operational burden, which became the core insight for Altro.
Their backgrounds form a complementary blend of commercial scale and clinical operations. CEO Andrea Corleto is a second-time founder who previously bootstrapped a consumer health brand, Silkkin, to seven-figure revenue [HBS Health Care Club, retrieved 2026]. She was also the first employee and Head of Growth at a consumer tech company she helped scale to a reported $1 billion valuation [Andrea Corleto website, retrieved 2026]. COO Jennifer Arnold brings over a decade of health industry experience, including a biomedical engineering background from Duke University and, critically, direct experience securing FDA approvals and running medical operations [Equilar ExecAtlas, retrieved 2026]. Both hold graduate degrees from Harvard Business School, having met during the program [Harvard Business School, retrieved 2026].
| Founder | Role | Key Background |
|---|---|---|
| Andrea Corleto | Co-Founder & CEO | Second-time founder (Silkkin); former Head of Growth at a $1B+ consumer tech company; HBS MBA 2026. |
| Jennifer Arnold | Co-Founder & COO | Biomedical engineer (Duke); 10+ years in health ops with FDA approval experience; HBS MS/MBA 2026. |
Scaling the Backend
With seed funding secured, Altro is now in a build-and-hire phase. Public job postings signal its priorities: senior full-stack engineers and a founding product manager in New York, plus a growth marketer role [Altro Health - Current Openings, retrieved 2026]. The hires suggest a focus on strengthening the core platform and beginning to drive customer acquisition.
The early traction claim of "thousands of users" is a start, but the more telling metric will be the number of businesses embedding Altro’s services and the volume of clinical transactions they generate. The company has not disclosed specific customer names or revenue figures. Its growth will depend on convincing wellness entrepreneurs that outsourcing clinical complexity is not just a convenience, but a prerequisite for safely and legally capturing the value of the longevity boom.
The Regulatory and Competitive Landscape
No venture into the prescription-augmented wellness space is without its watchouts. Altro’s model centralizes several key risks that any prudent observer would track.
- Clinical governance. The company’s reputation hinges on the quality and vigilance of its employed or contracted clinicians. Any lapse in appropriate prescribing or follow-up care could trigger regulatory scrutiny that impacts all its customers.
- Pharmacy economics. Managing the supply chain and cost for peptides and branded medications like GLP-1s is notoriously complex. Margins could be squeezed by drug pricing volatility or supply shortages.
- The incumbent response. While no direct competitors are named in sources, the space is attracting attention. Large telemedicine platforms or pharmacy benefit managers could decide to build similar tools for their networks, and established functional medicine clinics might view Altro as a disintermediation threat.
Altro’s answer to these risks is its infrastructure-first focus. By being the compliant backbone, it argues it can achieve a scale and specialization that individual clinics cannot, while its software layer creates a sticky operational dependency for its business customers.
The Standard of Care Today
The patient population here is broad, encompassing adults seeking optimization for energy, body composition, or age-related hormone decline. Today, the standard of care is frustratingly fragmented. A patient might get a lab panel ordered by a traditional doctor who dismisses subclinical results, then seek advice from a wellness coach who cannot prescribe, and finally turn to an online telehealth service with no continuity of care. This disjointed journey is what the wellness businesses partnering with Altro are trying to fix. They aim to become the single, trusted guide, combining lifestyle coaching with legitimate clinical intervention. Altro’s bet is that enabling this integrated model safely, at scale, is the infrastructure need of the moment.
For Altro Health, the next twelve months will be about proving that its infrastructure is not just viable, but indispensable. Key milestones will include landing flagship enterprise customers in the fitness and medspa chains, demonstrating repeatable unit economics, and perhaps most importantly, maintaining a spotless clinical safety record. In a market eager for science-backed longevity solutions, the company is betting that the real value isn’t in the front-end brand, but in the reliable, regulated engine humming in the background.
Sources
- [Athletech News, October 2026] Startup That Lets Personal Trainers Offer Labs, Peptides & HRT Raises $7 Million | https://athletechnews.com/altro-health-startup-that-lets-personal-trainers-offer-labs-peptides-hrt-raises-7-million/
- [NFX, June 2026] 3 Reasons Why NFX Invested in Altro Health: A Clinical Shopify for Wellness | https://www.nfx.com/post/altro-health
- [Altro Health Blog Post, October 2026] Altro Health Raised $7M to Build the Clinical Infrastructure Wellness Businesses Need | https://altrohealth.com/post/altro-health-raised-7m-to-build-the-clinical-infrastructure-wellness-businesses-need
- [Altro Health, retrieved 2026] Altro Health | The Clinical Infrastructure for Wellness Businesses | https://altrohealth.com/
- [PERPLEXITY SONAR PRO BRIEF, Unknown] Altro Health company brief
- [Harvard Business School, retrieved 2026] HBS announcement for Andrea Corleto and Jennifer Arnold | https://www.facebook.com/HarvardBusinessSchool/photos/hbs-has-announced-that-andrea-corleto-mba-2026-and-jennifer-arnold-msmba-2026-co/1548944263252128/
- [Andrea Corleto website, retrieved 2026] Andrea Corleto professional background | https://rocketreach.co/andrea-corleto-email_714414055
- [Equilar ExecAtlas, retrieved 2026] Jennifer Arnold professional profile
- [HBS Health Care Club, retrieved 2026] Andrea Corleto profile
- [Altro Health - Current Openings, retrieved 2026] Altro Health job listings | https://apply.workable.com/altro/
- [Founded by Women, retrieved 2026] Andrea Corleto and Silkkin profile